Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …

Prostate cancer is a highly heritable disease with large disparities in incidence rates across
ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer …

Genome-wide association studies (GWAS) have identified 76 variants associated with
prostate cancer risk predominantly in populations of European ancestry. To identify additional …

Background The optimal timing of radiotherapy after radical prostatectomy for prostate cancer
is uncertain. We aimed to compare the efficacy and safety of adjuvant radiotherapy versus …

Objective To study short-term (<90 days) morbidity and mortality following radical cystectomy
(RC) for bladder cancer and identify modifiable risk factors associated with these. Design …

Prostate cancer is a polygenic disease with a large heritable component. A number of common,
low-penetrance prostate cancer risk loci have been identified through GWAS. Here we …

Objectives To explore the effects of preoperative high‐intensity interval training (HIIT) compared
to usual care on tumour natural killer (NK)‐cell infiltration in men with localised prostate …

Background Having performed analytical validation studies, we are now assessing the
clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant …

Background Peptide-based vaccination is a rational option for immunotherapy of prostate
cancer. In this first-in-man phase I/II study, we assessed the safety, tolerability and …

Objective. The aim of this study was to record prostate-specific antigen (PSA) response and
overall survival (OS) for a group of metastatic castration-resistant prostate cancer (mCRPC) …